KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
about
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@en
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@nl
type
label
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@en
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@nl
prefLabel
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@en
KRAS-mutation incidence and pr ...... mutation and bone metastasis.
@nl
P2093
P2860
P50
P356
P1433
P1476
KRAS-mutation incidence and pr ...... S mutation and bone metastasis
@en
P2093
Ferenc Renyi-Vamos
Ilona Kovalszky
István Kenessey
Jozsef Timar
Judit Moldvay
Katalin Fabian
Walter Klepetko
Zoltan Lohinai
P2860
P2888
P356
10.1038/SREP39721
P407
P577
2017-01-04T00:00:00Z